Janus Henderson Group plc 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 12:01 pm Sale |
2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
JANUS HENDERSON GROUP PLC JHG |
1,240,153 2.200% |
-1,893,782 (-60.43%) |
Filing |
| 2022-02-10 5:02 pm Sale |
2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
JANUS HENDERSON GROUP PLC JHG |
3,133,935 6.200% |
-1,357,830 (-30.23%) |
Filing |
| 2021-02-11 5:11 pm Purchase |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
JANUS HENDERSON GROUP PLC JHG |
4,491,765 10.200% |
76,296 (+1.73%) |
Filing |
| 2020-05-11 11:58 am Purchase |
2020-04-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
JANUS HENDERSON GROUP PLC JHG |
4,415,469 10.000% |
110,221 (+2.56%) |
Filing |